| Indicators | Browse All

Nephros, Inc. (NEPH)

Healthcare | Medical Instruments & Supplies | South Orange, United States | NasdaqCM
3.55 USD -0.04 (-1.114%) ⇩ (July 14, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:26 a.m. EDT

The stock presents a classic case of a speculative turnaround play with severe execution risks. Fundamentally, the business is struggling: earnings have collapsed by 80%, free cash flow is negative, and the company is burning cash. While the price has recovered significantly over the last decade (+43%), the most recent annual performance shows a massive 67% surge, which masks the underlying operational weakness and suggests a volatile, bottom-fishing environment rather than sustainable growth. The balance sheet is fragile with negative operating cash flow, making it unsuitable for a long-term hold despite the low P/E multiple, which likely reflects market skepticism about future profitability. On the short end, the recent price action shows some resilience, trading above its 50-day moving average, but the statistical forecast model offers almost no directional guidance, indicating high uncertainty in the immediate term. With no dividend to provide income and a lack of clear catalysts beyond a generic product pitch, the investment case remains unproven.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.055915
AutoARIMA0.056678
AutoETS0.056678
AutoTheta0.134046

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 41%
H-stat 0.37
Ljung-Box p 0.000
Jarque-Bera p 0.344
Excess Kurtosis -1.06
Attribute Value
Sector Healthcare
Debt to Equity Ratio 9.046
Revenue per Share 1.8
Market Cap 38,540,736
Trailing P/E 50.71
Forward P/E 35.50
Beta 1.49
Profit Margins 4.06%
Website https://www.nephros.com

Info Dump

Attribute Value
52 Week Change 0.016997218
Address1 380 Lackawanna Place
All Time High 1,128.6
All Time Low 0.9
Ask 2.8
Ask Size 1
Average Daily Volume10 Day 10,750
Average Daily Volume3 Month 21,849
Average Volume 21,849
Average Volume10Days 10,750
Beta 1.494
Bid 3.27
Bid Size 1
Book Value 0.987
City South Orange
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 3.55
Current Ratio 4.549
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 3.6423
Day Low 3.418
Debt To Equity 9.046
Display Name Nephros
Dividend Date 1,562,716,800
Earnings Call Timestamp End 1,778,185,800
Earnings Call Timestamp Start 1,778,185,800
Earnings Growth -0.8
Earnings Quarterly Growth -0.749
Earnings Timestamp 1,778,184,000
Earnings Timestamp End 1,786,046,400
Earnings Timestamp Start 1,786,046,400
Ebitda 803,000
Ebitda Margins 0.041989997
Enterprise To Ebitda 44.198
Enterprise To Revenue 1.856
Enterprise Value 35,490,740
Eps Current Year 0.045
Eps Forward 0.1
Eps Trailing Twelve Months 0.07
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.4006
Fifty Day Average Change 0.1494
Fifty Day Average Change Percent 0.04393342
Fifty Two Week Change Percent 1.6997218
Fifty Two Week High 6.42
Fifty Two Week High Change -2.8700001
Fifty Two Week High Change Percent -0.4470405
Fifty Two Week Low 2.66
Fifty Two Week Low Change 0.88999987
Fifty Two Week Low Change Percent 0.3345864
Fifty Two Week Range 2.66 - 6.42
Financial Currency USD
First Trade Date Milliseconds 1,095,773,400,000
Float Shares 8,822,572
Forward Eps 0.1
Forward P E 35.5
Free Cashflow -773,500
Full Exchange Name NasdaqCM
Full Time Employees 36
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.59946
Gross Profits 11,464,000
Has Pre Post Market Data 1
Held Percent Insiders 0.12874
Held Percent Institutions 0.49638999
Implied Shares Outstanding 10,856,546
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Ir Website http://www.nephros.com/investors/stock-info-analysis/
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,562,716,800
Last Split Factor 1:9
Long Business Summary Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Long Name Nephros, Inc.
Market us_market
Market Cap 38,540,736
Market State PRE
Max Age 86,400
Message Board Id finmb_3661033
Most Recent Quarter 1,774,915,200
Net Income To Common 776,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 38,975,000
Number Of Analyst Opinions 2
Open 3.418
Operating Cashflow -348,000
Operating Margins 0.018609999
Payout Ratio 0.0
Phone 201 343 5202
Previous Close 3.59
Price Eps Current Year 78.888885
Price Hint 4
Price To Book 3.596758
Price To Sales Trailing12 Months 2.0153072
Profit Margins 0.04058
Quick Ratio 2.983
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.03999996
Regular Market Change Percent -1.1142051
Regular Market Day High 3.6423
Regular Market Day Low 3.418
Regular Market Day Range 3.418 - 3.6423
Regular Market Open 3.418
Regular Market Previous Close 3.59
Regular Market Price 3.55
Regular Market Time 1,784,059,200
Regular Market Volume 5,234
Return On Assets 0.03309
Return On Equity 0.07763
Revenue Growth 0.069
Revenue Per Share 1.8
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 10,856,546
Shares Percent Shares Out 0.0029
Shares Short 31,812
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 25,295
Short Name Nephros, Inc.
Short Percent Of Float 0.0047999998
Short Ratio 2.58
Source Interval 15
State NJ
Symbol NEPH
Target High Price 8.0
Target Low Price 6.0
Target Mean Price 7.0
Target Median Price 7.0
Total Cash 4,018,000
Total Cash Per Share 0.37
Total Debt 968,000
Total Revenue 19,124,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.07
Trailing P E 50.714283
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 4.10985
Two Hundred Day Average Change -0.55985
Two Hundred Day Average Change Percent -0.13622151
Type Disp Equity
Volume 5,234
Website https://www.nephros.com
Zip 7,079